| pubmed-article:16809734 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16809734 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:16809734 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:16809734 | lifeskim:mentions | umls-concept:C0879584 | lld:lifeskim |
| pubmed-article:16809734 | lifeskim:mentions | umls-concept:C1706668 | lld:lifeskim |
| pubmed-article:16809734 | lifeskim:mentions | umls-concept:C1522484 | lld:lifeskim |
| pubmed-article:16809734 | lifeskim:mentions | umls-concept:C0231221 | lld:lifeskim |
| pubmed-article:16809734 | lifeskim:mentions | umls-concept:C0036525 | lld:lifeskim |
| pubmed-article:16809734 | lifeskim:mentions | umls-concept:C1328504 | lld:lifeskim |
| pubmed-article:16809734 | lifeskim:mentions | umls-concept:C0205470 | lld:lifeskim |
| pubmed-article:16809734 | lifeskim:mentions | umls-concept:C0282461 | lld:lifeskim |
| pubmed-article:16809734 | pubmed:issue | 19 | lld:pubmed |
| pubmed-article:16809734 | pubmed:dateCreated | 2006-6-30 | lld:pubmed |
| pubmed-article:16809734 | pubmed:abstractText | Sipuleucel-T (APC8015) is an investigational immunotherapy product designed to stimulate T-cell immunity against prostatic acid phosphatase. A phase III study was undertaken to evaluate the safety and efficacy of sipuleucel-T in a placebo-controlled study. | lld:pubmed |
| pubmed-article:16809734 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16809734 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16809734 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16809734 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16809734 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16809734 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16809734 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16809734 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:16809734 | pubmed:issn | 1527-7755 | lld:pubmed |
| pubmed-article:16809734 | pubmed:author | pubmed-author:RedfernCharle... | lld:pubmed |
| pubmed-article:16809734 | pubmed:author | pubmed-author:SchellhammerP... | lld:pubmed |
| pubmed-article:16809734 | pubmed:author | pubmed-author:SmallEric JEJ | lld:pubmed |
| pubmed-article:16809734 | pubmed:author | pubmed-author:ValoneFrank... | lld:pubmed |
| pubmed-article:16809734 | pubmed:author | pubmed-author:HershbergRobe... | lld:pubmed |
| pubmed-article:16809734 | pubmed:author | pubmed-author:NemunaitisJoh... | lld:pubmed |
| pubmed-article:16809734 | pubmed:author | pubmed-author:HiganoCelesti... | lld:pubmed |
| pubmed-article:16809734 | pubmed:author | pubmed-author:JonesLori ALA | lld:pubmed |
| pubmed-article:16809734 | pubmed:author | pubmed-author:VerjeeSuleman... | lld:pubmed |
| pubmed-article:16809734 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:16809734 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:16809734 | pubmed:volume | 24 | lld:pubmed |
| pubmed-article:16809734 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16809734 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16809734 | pubmed:pagination | 3089-94 | lld:pubmed |
| pubmed-article:16809734 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:16809734 | pubmed:meshHeading | pubmed-meshheading:16809734... | lld:pubmed |
| pubmed-article:16809734 | pubmed:meshHeading | pubmed-meshheading:16809734... | lld:pubmed |
| pubmed-article:16809734 | pubmed:meshHeading | pubmed-meshheading:16809734... | lld:pubmed |
| pubmed-article:16809734 | pubmed:meshHeading | pubmed-meshheading:16809734... | lld:pubmed |
| pubmed-article:16809734 | pubmed:meshHeading | pubmed-meshheading:16809734... | lld:pubmed |
| pubmed-article:16809734 | pubmed:meshHeading | pubmed-meshheading:16809734... | lld:pubmed |
| pubmed-article:16809734 | pubmed:meshHeading | pubmed-meshheading:16809734... | lld:pubmed |
| pubmed-article:16809734 | pubmed:meshHeading | pubmed-meshheading:16809734... | lld:pubmed |
| pubmed-article:16809734 | pubmed:meshHeading | pubmed-meshheading:16809734... | lld:pubmed |
| pubmed-article:16809734 | pubmed:meshHeading | pubmed-meshheading:16809734... | lld:pubmed |
| pubmed-article:16809734 | pubmed:meshHeading | pubmed-meshheading:16809734... | lld:pubmed |
| pubmed-article:16809734 | pubmed:meshHeading | pubmed-meshheading:16809734... | lld:pubmed |
| pubmed-article:16809734 | pubmed:meshHeading | pubmed-meshheading:16809734... | lld:pubmed |
| pubmed-article:16809734 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:16809734 | pubmed:articleTitle | Placebo-controlled phase III trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer. | lld:pubmed |
| pubmed-article:16809734 | pubmed:affiliation | UCSF Comprehensive Cancer Center, University of California, San Francisco, 1600 Divisadero St, Box 1711, San Francisco, CA 94115, USA. smalle@medicine.ucsf.edu | lld:pubmed |
| pubmed-article:16809734 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16809734 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:16809734 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:16809734 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:16809734 | pubmed:publicationType | Clinical Trial, Phase III | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16809734 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16809734 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16809734 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16809734 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16809734 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16809734 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16809734 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16809734 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16809734 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16809734 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16809734 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16809734 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16809734 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16809734 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16809734 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16809734 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16809734 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16809734 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16809734 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16809734 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16809734 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16809734 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16809734 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16809734 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16809734 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16809734 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16809734 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16809734 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16809734 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16809734 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16809734 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16809734 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16809734 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16809734 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16809734 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16809734 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16809734 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16809734 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16809734 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16809734 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16809734 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16809734 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16809734 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16809734 | lld:pubmed |
